Since anti-CD25 treatment selectively depletes CD25+Foxp3+ Treg cells in peripheral blood but not in VAT, the finding supports a potential specific role for VAT Treg cells in improving insulin resistance in HT (25). Here, FOXP3 is linked to Insulin resistance.